Company · CIK 1865494
IO Biotech, Inc.
| CIK | 1865494 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | Denmark |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-12-17 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-288936 | 2025-07-24 | 2025-07-31 | 2 | |
| 333-287554 | 2025-05-23 | 2025-06-11 | 2 | |
| 333-274267 | 2023-08-30 | 2023-09-08 | 2 | |
| 333-269569 | 2023-02-03 | 2023-02-10 | 2 | |
| 333-260301 | 2021-10-15 | 2021-11-08 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-07-31 | EFFECTDeclared effective | 333-288936 | 9999999995-25-002438 |
| 2025-07-24 | S-3Shelf registered | 333-288936 | 0001193125-25-164495 |
| 2025-06-11 | EFFECTDeclared effective | 333-287554 | 9999999995-25-001891 |
| 2025-05-23 | S-3Shelf registered | 333-287554 | 0001193125-25-125831 |
| 2023-09-08 | EFFECTDeclared effective | 333-274267 | 9999999995-23-002615 |
| 2023-08-30 | S-3Shelf registered | 333-274267 | 0001193125-23-224946 |
| 2023-02-10 | EFFECTDeclared effective | 333-269569 | 9999999995-23-000385 |
| 2023-02-03 | S-3Shelf registered | 333-269569 | 0001193125-23-024343 |
| 2021-11-08 | 424B4Final prospectus | 333-260301 | 0001193125-21-323211 |
| 2021-11-04 | EFFECTDeclared effective | 333-260301 | 9999999995-21-004206 |
| 2021-11-01 | S-1/AAmendment | 333-260301 | 0001193125-21-314634 |
| 2021-10-26 | S-1/AAmendment | 333-260301 | 0001193125-21-308118 |
| 2021-10-15 | S-1Registration filed | 333-260301 | 0001193125-21-300173 |
| 2021-06-03 | DRSDraft made public | 377-04959 | 0000950123-21-007502 |